![Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-31492-5/MediaObjects/41598_2018_31492_Fig1_HTML.png)
Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports
![A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7e3b2f5b-a120-4600-8f2a-d8560c7d470e/gr1_lrg.jpg)
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International
![Policy narratives of circular economy in the EU – Assessing the embeddedness of water and land in national action plans - ScienceDirect Policy narratives of circular economy in the EU – Assessing the embeddedness of water and land in national action plans - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959652620357310-fx1.jpg)
Policy narratives of circular economy in the EU – Assessing the embeddedness of water and land in national action plans - ScienceDirect
![Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/01/04/2020.12.30.20249034/F2.large.jpg)
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv
![Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates | Cellular & Molecular Immunology Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00809-2/MediaObjects/41423_2021_809_Fig1_HTML.png)
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates | Cellular & Molecular Immunology
![Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/01/04/2020.12.30.20249034/F5.large.jpg)
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data | medRxiv
![Textiles and the environment: the role of design in Europe's circular economy — European Environment Agency Textiles and the environment: the role of design in Europe's circular economy — European Environment Agency](https://www.eea.europa.eu/publications/textiles-and-the-environment-the/textiles-and-the-environment-the/Figure1ComsumptionoftextilesFINAL.png)
Textiles and the environment: the role of design in Europe's circular economy — European Environment Agency
![Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre ... Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c4affcd6-1833-4ad8-a3fe-5c05c9ddfa5d/gr1.gif)
Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre ...
![Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality - Sletten - 2009 - Angewandte Chemie International Edition - Wiley Online Library Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality - Sletten - 2009 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/75b092c4-e564-4a2d-a28d-6689e93d603d/msch016.gif)
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality - Sletten - 2009 - Angewandte Chemie International Edition - Wiley Online Library
![Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML](https://www.mdpi.com/recycling/recycling-02-00006/article_deploy/html/images/recycling-02-00006-g001b.png)
Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML
![A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a1523976-0ac2-44b7-9f8e-84170f311f55/mfig002.jpg)